3730

GSK lifts stake in Indian consumer unit to 72.5%

The move will deepen the company’s footprint in emerging markets and non-prescription products
Comment E-mail Print Share
First Published: Tue, Feb 05 2013. 02 10 PM IST
Britain’s biggest drug maker announced plans to acquire larger holdings in both its Indian and Nigerian consumer product businesses in November.
Britain’s biggest drug maker announced plans to acquire larger holdings in both its Indian and Nigerian consumer product businesses in November.
London: GlaxoSmithKline Plc has lifted its stake in its publicly-listed Indian consumer healthcare subsidiary to 72.5% from 43.2%, deepening its footprint in emerging markets and non-prescription products.
David Redfern, GSK’s chief strategy officer, said on Tuesday the £568 million Indian transaction would “further increase our exposure to a key emerging market”.
Britain’s biggest drug maker announced plans to acquire larger holdings in both its Indian and Nigerian consumer product businesses in November.
Comment E-mail Print Share
First Published: Tue, Feb 05 2013. 02 10 PM IST
blog comments powered by Disqus
  • Wed, Jul 23 2014. 06 06 PM
  • Wed, Jul 16 2014. 06 10 PM
ALSO READ close

Emerging-market stocks advance on China as Russian shares slide

Subscribe |  Contact Us  |  mint Code  |  Privacy policy  |  Terms of Use  |  Advertising  |  Mint Apps  |  About HT Media  |  Jobs
Contact Us
Copyright © 2014 HT Media All Rights Reserved